Cas:168050-39-3 benzyl N-[(4-aminophenyl)methyl]carbamate manufacturer & supplier

We serve Chemical Name:benzyl N-[(4-aminophenyl)methyl]carbamate CAS:168050-39-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

benzyl N-[(4-aminophenyl)methyl]carbamate

Chemical Name:benzyl N-[(4-aminophenyl)methyl]carbamate
CAS.NO:168050-39-3
Synonyms:benzyl 4-aminobenzylcarbamate;4-N-Cbz-Aminomethylaniline
Molecular Formula:C15H16N2O2
Molecular Weight:256.30000
HS Code:2924299090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:472.9ºC at 760 mmHg
Density:1.197g/cm3
Index of Refraction:1.613
PSA:64.35000
Exact Mass:256.12100
LogP:3.66730

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like benzyl 4-aminobenzylcarbamate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-N-Cbz-Aminomethylaniline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-N-Cbz-Aminomethylaniline Use and application,4-N-Cbz-Aminomethylaniline technical grade,usp/ep/jp grade.


Related News: The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency. benzyl N-[(4-aminophenyl)methyl]carbamate manufacturer Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country. benzyl N-[(4-aminophenyl)methyl]carbamate supplier The Big Pharma had, however, decided to all but shelve donanemab in the near term as it couldn’t see a regulatory path forward. benzyl N-[(4-aminophenyl)methyl]carbamate vendor The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency. benzyl N-[(4-aminophenyl)methyl]carbamate factory Once they have decided how to make the compound, our staff in the production department manufacture a high quantity of APIs using the large reactors in our plant.